Latest valproic acid Stories
By John Dorschner, The Miami Herald Jul. 31--Noven Pharmaceuticals, the drug maker with headquarters in South Miami-Dade, said the U.S.
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration (FDA) has approved Stavzor(TM) (valproic acid delayed release capsules) in 125 mg, 250 mg and 500 mg strengths.
Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, today announced that the US Food & Drug Administration (FDA) has granted final approval for the Company's New Drug Application (NDA) for Valproic Acid Delayed Release soft gelatin capsules in the 125 mg, 250 mg, and 500 mg strengths.
Researchers in Victoria, Australia have developed a new genetic test to help predict the response of epilepsy sufferers to commonly used drug treatments.
By Anthony J. Brown, MD NEW YORK (Reuters Health)
By Will Boggs, MD NEW YORK (Reuters Health) - Women who use anticonvulsants during pregnancy may increase the risk of delivering an infant with a rare condition called craniostenosis, a study hints. The skull consists of five thin, curved, bony plates that meet along lines called sutures.
Scientists investigating epilepsy at the University of Liverpool have found no significant long-term benefit in administering immediate treatment to those with early epilepsy and infrequent seizures.